1. Effects of tocilizumab versus hemoadsorption combined with tocilizumab in patients with SARS-CoV-2 pneumonia: Preliminary results
- Author
-
Stefania Pintacuda, Giacomo Paluzzano, Ariella Tomasini, Antonino Chillemi, Irene Longo, Alice Scamperle, Edoardo Moro, Roberto Dattola, Giorgio Berlot, Erik Roman-Pognuz, Berlot, G., Pintacuda, S., Moro, E., Paluzzano, G., Scamperle, A., Chillemi, A., Longo, I., Dattola, R., Roman-Pognuz, E., and Tomasini, A.
- Subjects
Adult ,sepsis mediator ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Biomedical Engineering ,interleukin 6 ,Medicine (miscellaneous) ,Bioengineering ,hemoadsorption ,SARS-CoV-2 ,sepsis mediators ,septic shock ,tocilizumab ,Antibodies, Monoclonal, Humanized ,Humans ,Retrospective Studies ,COVID-19 ,Antibodies ,Biomaterials ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Tocilizumab ,Retrospective Studie ,Monoclonal ,Medicine ,In patient ,030212 general & internal medicine ,Interleukin 6 ,Humanized ,030304 developmental biology ,0303 health sciences ,biology ,business.industry ,Septic shock ,General Medicine ,medicine.disease ,COVID-19 Drug Treatment ,Pneumonia ,chemistry ,Immunology ,biology.protein ,business ,Human - Abstract
Objective: To assess the variations of Interleukin-6 (IL-6) in patients with SARS-CoV-2 infection treated with Tocilizumab (TCZ) alone or in association with hemoadsorption (HA). Design: Retrospective. Setting: An Intensive Care Unit (ICU) admitting mechanically ventilated patients with SARS-CoV-2 pneumonia. Patients: Four adult patients. Interventions: We compared the blood values of IL-6, C-reactive protein (CRP) and of other biochemical variables including the PaO2/FiO2 in two patients who received TCZ alone and in other 2 in whom it was associated with the HA (TCZ-HA) due to the presence of impending or established organ failures other than the lung. All variables were measured before, during and after the treatment. Main results: In all patients, the IL-6 increased during the treatment; after its termination, its values sharply decreased only in those treated also with HA; conversely, the CRP decreased in all patients; the PaO2/FiO2 increased in three patients and remained stable in the remaining one. Both the TCZ and the HA were well tolerated; all patients were weaned from the mechanical ventilation and discharged from the hospital. Limitations: Although the limited number of patients does not allow to draw firm conclusions, the increase of the IL-6 of can be ascribed to its displacement from cellular and soluble receptors, whereas its decrease is likely due to the scavenging effect exerted by the HA. Although the association TCZ-HA could be valuable in the treatment of the Cytokine Release Storm (CRS) associated with the SARS-CoV-2, the HA could be more effective as it neutralizes a wider panel of inflammatory mediators.
- Published
- 2021
- Full Text
- View/download PDF